Developing non-addictive pain relief medications
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
['FUNDING_OTHER'] · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · NIH-10512672
This study is working on new pain relief medicines that help manage pain without the risk of addiction, making them safer options for people dealing with chronic pain.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-10512672 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new pain relief medications that do not have the addictive properties associated with opioids. It aims to target specific sites on the cannabinoid CB1 receptor to develop small molecule analgesics that can effectively manage pain without the harmful side effects of traditional painkillers. By using a novel approach that enhances the receptor's function without activating it in a way that leads to dependence, the research seeks to provide safer alternatives for chronic pain management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing chronic pain who are seeking alternatives to opioid medications.
Not a fit: Patients who do not experience chronic pain or those who are not interested in alternative pain management strategies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer, non-addictive pain relief options for patients suffering from chronic pain.
How similar studies have performed: Previous research has shown promise in developing similar allosteric modulators for cannabinoid receptors, indicating potential for success in this novel approach.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LU, DAI — TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
- Study coordinator: LU, DAI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.